Rekombinanter IRF4 Antikörper (C-Term)
Kurzübersicht für Rekombinanter IRF4 Antikörper (C-Term) (ABIN7877403)
Target
Alle IRF4 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- IRF4 Antibody / Interferon regulatory factor 4 / MUM1
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant partial protein sequence from the C-terminal region of the human protein was used as the immunogen for the IRF4 antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the IRF4 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Aliquot the IRF4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- IRF4 (Interferon Regulatory Factor 4 (IRF4))
-
Andere Bezeichnung
- IRF4
-
Hintergrund
- Interferon regulatory factor 4 (IRF4), also called Multiple myeloma oncogene 1 (MUM1) is one of nuclear transcription factors necessary for development and activation of B lymphocytes.
-
UniProt
- Q15306
-
Pathways
- Chromatin Binding
Target
-